CIK 0001515673 · Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272546083
- Phone
- 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-20 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Grant or award | +1,000 | 24,614 | ||
| 2023-10-23 | Kassberg Thomas Richard CBO & EVP | Option exercise 10b5-1 | +39,878 | $6.86 | $274K | 286,738 |
| 2023-10-23 | Kassberg Thomas Richard CBO & EVP | Sale 10b5-1 | −39,878 | $32.78 | $1.3M | 246,860 |
| 2023-10-23 | Kassberg Thomas Richard CBO & EVP | Option exercise · Stock Option (Right to Buy) 10b5-1 | −39,878 | 0 |
Page 11 of 11 · 204 trades